Navitas Life Sciences, a TAKE Solutions Enterprise, provides services and technology to deliver “first to file” results to generic drug companies around the globe,...
Navitas Life Sciences, a wholly owned subsidiary of TAKE Solutions and an end-to-end provider of transformative solutions across the spectrum of Clinical, Regulatory and Safety in Life Sciences ,...
Navitas industry networks recently celebrated its milestone 15th year of delivering insights and creating dialogue to address industry challenges and benchmark practices...
Navitas, a technology-led Life Sciences services provider across Clinical, Regulatory and Safety, announced that it would be augmenting its capabilities with the niche expertise of its legacy brands,...
Navitas Life Sciences welcomes the opportunity to provide comments on this Reflection Paper...
Navitas Life Sciences announced the appointment of Dr. Krishnan Rajagopalan as Chief Growth Officer. As the Chief Growth Officer, Krishnan will oversee Navitas’ sales and marketing efforts,...
The Navitas Life Sciences Networks are pleased to confirm the dates for our upcoming Spring forums...
Regulators are changing the way they look at labeling. The emphasis is on ensuring Marketing Authorization Holders have a linked up End-to-End (E2E) process...
BioVectra has chosen pharmaREADY for its eCTD requirements. BioVectra, located in Canada, manufactures ingredients for global pharmaceutical and biotechnology clients, ...
Navitas Life Sciences Principal Jeffrey Ho will present "Efficient content management for the compilation and management of the PSMF" at the DIA 10th Annual Forum , ...